This is a Open-label multicenter study to evaluate the ability of CGB-400 Gel to reduce facial redness typically associated with rosacea. Approximately 25 subjects will be enrolled.~Subjects will receive study treatment for 4 weeks and attend a total of 4 study visits (BL, W1, W2, W4).
Open-label multicenter study using CGB-400 Gel (cosmetic) to reduce facial redness